Weight-loss drugs from Lilly, Novo linked to stalling cancer: report

Health

Weight-Loss Drugs From Lilly, Novo Linked To Stalling Cancer: Report

By Seeking Alpha

May 22, 2026, 6:47 AM ETNovo Nordisk A/S (NVO) Stock, LLY StockBy : Arundhati Sarkar, SA News Editor Comments (12) The world’s most popular weight-loss and diabetes drugs are linked to a powerful new possible benefit: better outcomes for cancer patie ...Read more

Related Posts

For Ronda Rousey, Netflix win was both 'closure' and an exorcism: 'I feel like a ghost was banished'

For Ronda Rousey, Netflix win was both 'closure' and an exorcism: 'I feel like a ghost was banished'

May 17, 2026
Number of steps a day to maintain weight loss isn't 10,000

Number of steps a day to maintain weight loss isn't 10,000

May 10, 2026
Penn study: Inconsistent GLP‑1 use may lead to weight gain

Penn study: Inconsistent GLP‑1 use may lead to weight gain

May 15, 2026
Scientists say 8,500 steps a day could stop weight from creeping back

Scientists say 8,500 steps a day could stop weight from creeping back

May 11, 2026
We use cookies to help provide you with the best experience when you visit our websites. By using this site you consent to the use of cookies on your device. see our cookie policy.